Healthcare Realty Trust Incorporated Financial Ratios — HR

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-0.02	0.51	0.59	2.59	5.64	5.91	1.34	3.98	2.17	3.75	3.23	0.84	-3.87	-10.86	-5
Return on Assets (%)	-0.01	0.22	0.26	1.16	2.49	2.92	0.74	2.19	1.16	1.96	1.65	0.45	-2.1	-5.62	-2.48
Return on Capital (%)	- -	- -	- -	3.87	4.97	5.01	2.57	4	2.94	3.62	3.08	2.16	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	3.98	4.04	3.81	3.07	2.65	2.39	2.31	2.2	0.94	- -	- -	- -
Gross Margin (%)	58.57	61.15	62.29	63.29	63.44	63.57	62.29	61.46	61.06	60.08	59.53	62.56	62.27	62.1	61.03
EBITDA Margin (%)	58.26	59.93	59.41	60.2	59.28	59.04	57.17	56.14	55.92	56.23	55.7	61	62.59	60.75	61.28
Operating Margin (%)	24.13	25.14	27.01	28.42	27.89	26.46	22.07	18.35	16.79	16.65	16.33	9.01	4.09	2.93	8.24
Incremental Operating Margin (%)	77.74	38.26	43.33	39.82	17.33	-2.76	-97.52	-42.68	-17.97	14.54	11.47	-0.73	-7.01	22.83	-60.25
Pretax Margin (%)	-4.26	-0.31	-4.03	9.3	15.34	21.28	5.54	15.77	8.48	14.67	12.71	4.43	-21.27	-53.15	-21.65
Profit Margin (%)	-0.08	1.87	2.14	8.73	18.11	21.28	5.54	15.77	8.48	14.67	12.71	4.45	-20.98	-52.39	-21.35
Net Income to Common Margin (%)	-0.08	1.87	2.14	8.73	18.11	21.28	5.54	15.77	8.48	14.67	12.71	4.45	-20.98	-52.39	-21.35
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	-775.38	-11,722.14	-854.62	339.35	204.41	153.98	616.35	215.37	396.47	225.16	263.21	3,475.91	-165.17	-68	-152.99
Sustainable Growth Rate (%)	-0.2	60.79	5.61	-6.19	-5.88	-3.19	-6.93	-4.59	-6.42	-4.7	-5.26	-28.3	-10.25	-18.24	-12.64

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1,394	1,293	1,348	1,404	1,431	1,264	1,284	1,346	1,524	1,714	1,920	5,705	5,299	4,960	4,147
ST Debt	- -	110	238	85	206	107	189	262	293	- -	210	349	350	- -	120
LT Debt	1,394	1,183	1,110	1,319	1,225	1,157	1,095	1,084	1,231	1,714	1,710	5,356	4,949	4,960	4,027
Total Debt/EBITDA	8.84	7.4	6.98	6.39	6.3	5.32	5.39	5.42	5.89	6.19	6.57	10.18	6.38	6.54	5.87
Net Debt/EBITDA	8.81	7.36	6.94	6.37	6.28	5.3	5.36	5.39	5.47	5.74	6.12	9.44	5.99	6.05	5.5
Total Debt/EBIT	21.33	17.64	15.36	13.52	13.39	11.88	13.95	16.58	19.63	20.91	22.41	68.91	97.74	135.51	43.69
Net Debt/EBIT	21.26	17.54	15.26	13.49	13.35	11.83	13.88	16.48	18.21	19.37	20.87	63.91	91.65	125.52	40.92
EBITDA to Interest Expense	2.19	2.43	2.75	3.17	3.65	4.36	4.43	4.7	4.6	4.93	5.5	3.78	3.21	3.2	3.41
EBITDA-CapEx/Interest Expense	-1.01	1.57	1.71	2.15	2.86	3.05	2.93	3.36	3.45	3.25	3.6	2.68	2.32	2.15	1.81
EBIT to Interest Expense	0.91	1.02	1.25	1.5	1.72	1.96	1.71	1.54	1.38	1.46	1.61	0.56	0.21	0.15	0.46
Interest Expense	72	72	70	69	62	54	54	53	56	56	53	148	259	237	207
Common Equity/Total Assets	39.86	44.13	45.55	44.28	44.12	54.38	56.05	53.79	53.31	51.11	51.31	54.67	53.99	49.15	50.12
Long-Term Debt/Equity (%)	138.69	105.54	89.17	108	98.61	70	61.17	63.15	64.77	87.96	78.26	69.72	71.49	93.47	86.12
Long-Term Debt/Capital (%)	58.1	49.01	42.81	50.24	45.83	39.67	35.62	35.39	35.95	46.8	41.66	40.01	40.5	48.31	45.64
Long-Term Debt/Total Assets (%)	55.28	46.58	40.68	47.82	43.51	38.06	34.28	33.97	34.53	44.96	40.15	38.67	39.16	46.57	43.73
Total Debt/Equity (%)	138.69	115.35	108.29	114.96	115.19	76.47	71.73	78.41	80.19	87.96	87.87	74.26	76.55	93.47	88.69
Total Debt/Capital (%)	58.1	53.56	51.99	53.48	53.53	43.33	41.77	43.95	44.5	46.8	46.77	42.62	43.36	48.31	47
Total Debt/Total Assets (%)	55.28	50.91	49.4	50.9	50.82	41.58	40.2	42.18	42.75	44.96	45.08	41.19	41.93	46.57	45.03
Net Debt to Equity	138.22	114.75	107.59	114.67	114.86	76.14	71.38	77.92	74.39	81.48	81.83	68.88	71.78	86.58	83.08
Net Debt/Capital (%)	58.02	53.43	51.83	53.42	53.46	43.23	41.65	43.79	41.29	43.53	43.7	39.7	40.74	45.05	44.16
EBITDA	158	175	193	220	227	237	238	248	258	277	292	561	830	759	706
EBITDA-CapEx	-72	113	120	149	179	166	158	178	194	183	191	397	599	510	376
Operating Income (Loss)	65	73	88	104	107	106	92	81	78	82	86	83	54	37	95

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.04	0.03	0.02	0.01	0.03	0.02	0.02	- -	0.19	0.04	0.1	0.05	0.31	0.08
Current Ratio	- -	1.5	0.78	0.88	0.49	1.05	0.69	0.48	0.35	1.99	0.46	0.68	0.9	2.35	1.75
Quick Ratio	- -	1.19	0.58	0.43	0.26	0.42	0.31	0.26	0.23	1.13	0.29	0.51	0.67	1.6	0.82
CFO/Avg Current Liab	- -	1.32	0.49	0.54	0.7	0.65	0.81	0.69	0.6	2.07	1.1	0.58	0.86	1.28	1.6
Common Equity/Total Assets	39.86	44.13	45.55	44.28	44.12	54.38	56.05	53.79	53.31	51.11	51.31	54.67	53.99	49.15	50.12
Long-Term Debt/Equity (%)	138.69	105.54	89.17	108	98.61	70	61.17	63.15	64.77	87.96	78.26	69.72	71.49	93.47	86.12
Long-Term Debt/Capital (%)	58.1	49.01	42.81	50.24	45.83	39.67	35.62	35.39	35.95	46.8	41.66	40.01	40.5	48.31	45.64
Long-Term Debt/Total Assets (%)	55.28	46.58	40.68	47.82	43.51	38.06	34.28	33.97	34.53	44.96	40.15	38.67	39.16	46.57	43.73
Total Debt/Equity (%)	138.69	115.35	108.29	114.96	115.19	76.47	71.73	78.41	80.19	87.96	87.87	74.26	76.55	93.47	88.69
Total Debt/Capital (%)	58.1	53.56	51.99	53.48	53.53	43.33	41.77	43.95	44.5	46.8	46.77	42.62	43.36	48.31	47
Total Debt/Total Assets (%)	55.28	50.91	49.4	50.9	50.82	41.58	40.2	42.18	42.75	44.96	45.08	41.19	41.93	46.57	45.03
CFO/Total Liabilities	7.11	8.2	8.14	8.16	9.78	10.9	12.81	14.13	12.81	25.22	11.22	4.42	8.75	9.38	10.08
CFO/CapEx	0.47	1.87	1.66	1.77	3.16	2.12	2.23	2.94	3.3	5	2.31	1.67	2.16	2.01	1.38
Altman's Z-Score	0.27	1.59	1.44	1.74	1.75	2.24	2.36	2.09	2.18	2	1.93	0.92	0.92	0.88	1

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	14.55	7.32	6.67	5.91	5.68	5.68	5.77	5.68	6.09	6.43	8.05	8.2	7.31	6.95
Days Sales Outstanding	- -	25.09	49.86	54.72	61.78	64.25	64.21	63.24	64.24	59.95	56.73	45.36	44.53	49.9	52.53
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.92	9.25	17.45	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.65	39.46	20.92	- -	- -
Cash Conversion Cycle	- -	25.09	49.86	54.72	61.78	64.25	64.21	63.24	64.24	59.95	42.09	5.9	23.61	49.9	52.53
Inventory to Cash Days	- -	25.09	49.86	54.72	61.78	64.25	64.21	63.24	64.24	59.95	56.73	45.36	44.53	49.9	52.53
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	1,447	2,101	2,044	2,700	2,875	3,530	4,019	3,563	4,495	4,129	4,760	7,334	6,564	5,942	5,960
- Cash & Cash Equivalents	5	7	9	4	4	5	6	8	1	15	13	61	26	69	26
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	2	- -	- -	- -	- -	- -	- -	- -	- -	111	100	71	60
+ Total Debt	1,394	1,293	1,348	1,404	1,431	1,264	1,284	1,346	1,524	1,714	1,920	5,705	5,299	4,960	4,147
Enterprise Value	2,836	3,387	3,386	4,100	4,302	4,789	5,297	4,901	6,018	5,827	6,667	13,088	11,938	10,903	10,141
Total Capital	2,398	2,414	2,594	2,625	2,674	2,918	3,074	3,063	3,424	3,662	4,105	13,386	12,222	10,265	8,824
Total Debt/Capital (%)	58.1	53.56	51.99	53.48	53.53	43.33	41.77	43.95	44.5	46.8	46.77	42.62	43.36	48.31	47
Total Debt / EV	0.49	0.38	0.4	0.34	0.33	0.26	0.24	0.27	0.25	0.29	0.29	0.44	0.44	0.45	0.41
EV/Sales	10.48	11.62	10.42	11.23	11.22	11.91	12.7	11.08	13.02	11.84	12.71	14.24	9	8.73	8.8
EV/EBITDA	17.98	19.38	17.53	18.65	18.93	20.17	22.22	19.73	23.28	21.05	22.82	23.35	14.38	14.37	14.36
EV/EBIT	43.42	46.2	38.57	39.51	40.23	45	57.56	60.37	77.55	71.09	77.82	158.11	220.18	297.91	106.82
EV/Cash Flow to Firm	15.78	18	17.72	21.06	19.89	23.28	22.68	18.76	22.35	11.07	23.33	31.09	15.74	14.76	15.26
EV/Free Cash Flow to Firm	6.92	13.53	12.83	15.45	16.23	17.28	16.86	14.76	18.02	9.4	17.25	22.39	12.07	11.04	10.2
Diluted Market Cap	1,352	1,893	1,938	2,643	2,829	3,317	3,791	3,508	4,274	3,967	4,515	4,892	6,529	6,196	5,929
Diluted Enterprise Value	2,741	3,179	3,280	4,044	4,256	4,576	5,068	4,846	5,797	5,665	6,422	10,647	11,902	11,158	10,110
EV per Share	36.43	38.71	35.3	41.49	42.38	41.13	42.33	39.12	44.68	41.78	44.31	34.39	31.33	31.1	28.84
TTM Sales	271	292	325	365	383	402	417	442	462	492	525	919	1,326	1,249	1,152
TTM EBITDA	158	175	193	220	227	237	238	248	258	277	292	561	830	759	706
TTM Operating Income	65	73	88	104	107	106	92	81	78	82	86	83	54	37	95
TTM Cash Flow to Firm	180	188	191	195	216	206	234	261	269	526	286	421	758	739	664
TTM Free Cash Flow to Firm	410	250	264	265	265	277	314	332	334	620	386	585	989	988	995

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	4	10.6	10.01	13.48	13.95	14.89	14.56	12.57	15.39	7.03	13.55	11.21	8.93	8.25	7.53
EV/EBIT	43.42	46.2	38.57	39.51	40.23	45	57.56	60.37	77.55	71.09	77.82	158.11	220.18	297.91	106.82
Enterprise Value	2,836	3,387	3,386	4,100	4,302	4,789	5,297	4,901	6,018	5,827	6,667	13,088	11,938	10,903	10,141
Low Price	13.83	18.52	20.91	20.85	22.01	26.66	29.67	26.09	27.43	24.1	28	18.16	13.86	12.77	14.09
EV/Sales	10.48	11.62	10.42	11.23	11.22	11.91	12.7	11.08	13.02	11.84	12.71	14.24	9	8.73	8.8
EV/EBITDA	17.98	19.38	17.53	18.65	18.93	20.17	22.22	19.73	23.28	21.05	22.82	23.35	14.38	14.37	14.36
Price/Earnings	- -	346.4	279	81.63	40.45	38.47	164.03	50.26	109	54.91	67.7	118.91	- -	- -	- -
Price/Earnings Average	-6,744.43	325.66	330.39	73.79	37.11	40.13	166.14	50.76	105.38	56.87	66.31	156.84	-24.66	-9.19	-23.66
Price/Earnings High	-8,063.76	362.99	400.5	83.66	44.56	46.44	185.12	56.94	113.97	70.44	72.26	199.8	-30.45	-10.56	-26.97
Price/Earnings Low	-4,699.61	267.19	273.77	62.3	31.44	33.83	151.52	46.1	89.6	44.71	59.91	112.06	-18.87	-7.13	-20.03
Price/Book Value	1.44	1.87	1.64	2.21	2.31	2.13	2.25	2.08	2.37	2.12	2.18	0.97	0.96	1.13	1.29
Price/Book Value Average	1.54	1.76	1.95	2	2.12	2.23	2.27	2.1	2.29	2.19	2.13	1.28	1.01	1.1	1.27
Price/Book Value High	1.84	1.96	2.36	2.27	2.55	2.58	2.53	2.35	2.47	2.72	2.33	1.63	1.25	1.27	1.44
Price/Book Value Low	1.07	1.45	1.61	1.69	1.8	1.88	2.07	1.9	1.94	1.73	1.93	0.91	0.77	0.86	1.07
Price/Tangible Book Value	1.44	1.91	1.67	2.25	2.36	2.17	2.27	2.1	2.37	2.13	2.19	1.01	1.01	1.14	1.3
Price/Tangible Book Value Average	1.54	1.79	1.98	2.04	2.16	2.26	2.3	2.12	2.3	2.2	2.14	1.33	1.06	1.11	1.27
Price/Tangible Book Value High	1.84	2	2.4	2.31	2.6	2.62	2.57	2.38	2.48	2.73	2.34	1.7	1.31	1.27	1.45
Price/Tangible Book Value Low	1.07	1.47	1.64	1.72	1.83	1.91	2.1	1.93	1.95	1.73	1.94	0.95	0.81	0.86	1.08
Price/Sales	4.99	6.49	5.96	7.13	7.32	8.18	9.08	7.93	9.24	8.05	8.6	5.29	4.92	4.96	5.15
Price/Sales Average	5.33	6.1	7.06	6.44	6.72	8.54	9.2	8.01	8.93	8.34	8.43	6.98	5.17	4.81	5.05
Price/Sales High	6.37	6.8	8.56	7.31	8.07	9.88	10.25	8.98	9.66	10.33	9.18	8.89	6.39	5.53	5.76
Price/Sales Low	3.72	5.01	5.85	5.44	5.69	7.2	8.39	7.27	7.6	6.56	7.61	4.99	3.96	3.74	4.28
Price/Cash Flow	12.53	16.26	16.04	20.76	18.24	21.76	21.07	16.83	20.04	8.43	19.4	17.83	13.06	12.35	12.97
Price/Cash Flow Average	13.38	15.29	19	18.77	16.73	22.7	21.34	17	19.37	8.73	19	23.52	13.73	11.98	12.74
Price/Cash Flow High	16	17.04	23.03	21.28	20.09	26.27	23.78	19.07	20.95	10.82	20.71	29.96	16.95	13.77	14.52
Price/Cash Flow Low	9.32	12.55	15.74	15.85	14.18	19.13	19.46	15.44	16.47	6.87	17.17	16.8	10.51	9.31	10.78
Price/Free Cash Flow Average	4.27	9.96	11.86	12.19	12.8	15.54	14.75	12.69	14.87	7.28	13.27	14.79	9.39	8.01	7.4
Price/Free Cash Flow High	5.11	11.1	14.37	13.82	15.37	17.98	16.43	14.24	16.09	9.02	14.46	18.84	11.59	9.2	8.43
Price/Free Cash Flow Low	2.98	8.17	9.82	10.29	10.84	13.09	13.45	11.53	12.65	5.73	11.99	10.57	7.19	6.22	6.26
EV/Sales Average	10.84	11.18	11.58	10.52	10.6	12.29	12.83	11.16	12.7	12.14	12.52	16.79	9.25	8.59	8.71
EV/Sales High	11.95	11.96	13.16	11.41	11.98	13.72	13.94	12.15	13.46	14.21	13.32	19.67	10.47	9.28	9.42
EV/Sales Low	9.11	9.97	10.3	9.48	9.55	10.85	11.97	10.41	11.29	10.28	11.67	13.78	8.03	7.56	7.93
EV/EBITDA Average	18.6	18.66	19.48	17.47	17.88	20.81	22.44	19.88	22.7	21.59	22.48	27.52	14.78	14.13	14.21
EV/EBITDA High	20.52	19.96	22.14	18.96	20.21	23.24	24.39	21.64	24.08	25.27	23.92	32.25	16.73	15.27	15.37
EV/EBITDA Low	15.63	16.63	17.33	15.74	16.11	18.37	20.94	18.55	20.19	18.28	20.94	22.6	12.83	12.44	12.94
EV/EBIT Average	44.92	44.49	42.86	37.01	38.01	46.43	58.12	60.82	75.62	72.88	76.68	186.37	226.34	293.08	105.68
EV/EBIT High	49.54	47.57	48.71	40.15	42.96	51.86	63.18	66.21	80.18	85.33	81.56	218.38	256.22	316.59	114.3
EV/EBIT Low	37.74	39.65	38.13	33.34	34.24	40.99	54.23	56.75	67.24	61.73	71.43	153	196.5	257.88	96.22
Last Price	18.59	24.01	21.31	27.32	28.32	30.32	32.12	28.44	33.37	29.6	31.64	19.27	17.23	16.95	16.95
High Price	23.73	25.16	30.59	28	31.2	36.6	36.25	32.22	34.89	37.97	33.77	32.38	22.36	18.9	18.97
Enterprise Value Average	2,934	3,262	3,762	3,841	4,065	4,941	5,349	4,937	5,868	5,975	6,570	15,428	12,271	10,726	10,033
Enterprise Value High	3,236	3,488	4,276	4,167	4,595	5,520	5,814	5,374	6,223	6,995	6,988	18,078	13,892	11,587	10,851
Enterprise Value Low	2,465	2,907	3,347	3,461	3,662	4,363	4,990	4,606	5,218	5,060	6,120	12,666	10,654	9,438	9,135

Shares Outstanding	78	88	96	99	102	116	125	125	135	139	150	381	381	351	352
Diluted Weighted Avg Shares	73	79	91	97	100	109	118	123	128	134	143	254	379	366	350
Basic Weighted Avg Shares	73	79	91	95	99	109	118	123	128	134	143	252	379	366	350
Revenue per Share	3.72	3.7	3.57	3.83	3.87	3.7	3.54	3.59	3.61	3.68	3.68	3.64	3.5	3.42	3.29
EBITDA per Share	2.17	2.22	2.12	2.31	2.29	2.19	2.02	2.01	2.02	2.07	2.05	2.22	2.19	2.08	2.02
Operating Income per Share	0.9	0.93	0.97	1.09	1.08	0.98	0.78	0.66	0.61	0.61	0.6	0.33	0.14	0.1	0.27
Basic EPS, GAAP	- -	0.07	0.08	0.33	0.7	0.79	0.2	0.57	0.31	0.54	0.47	0.16	-0.73	-1.79	-0.7
Basic EPS from Cont Ops	-0.16	-0.01	-0.14	0.36	0.59	0.79	0.2	0.57	0.31	0.54	0.47	0.16	-0.74	-1.82	-0.71
Diluted EPS, GAAP	- -	0.07	0.08	0.33	0.7	0.78	0.2	0.57	0.31	0.54	0.47	0.16	-0.73	-1.79	-0.7
Diluted EPS from Cont Ops	-0.16	-0.01	-0.14	0.35	0.59	0.78	0.2	0.57	0.31	0.54	0.47	0.16	-0.74	-1.82	-0.71
Dividend per Share	1.23	1.22	1.23	1.22	1.21	1.21	1.21	1.22	1.21	1.21	1.23	5.58	1.25	1.25	1.11
Cash Flow per Share	1.48	1.48	1.33	1.32	1.55	1.39	1.52	1.69	1.67	3.51	1.63	1.08	1.32	1.37	1.31
Free Cash Flow per Basic Share	-1.68	0.69	0.53	0.57	1.06	0.74	0.84	1.12	1.16	2.81	0.93	0.43	0.71	0.69	0.36
Cash & Equivalents per Share	0.06	0.08	0.09	0.04	0.04	0.05	0.05	0.07	- -	0.11	0.09	0.16	0.07	0.2	0.07
Book Value per Share	12.91	12.81	12.96	12.36	12.24	14.2	14.3	13.7	14.1	13.97	14.52	19.89	17.91	14.93	13.13
Tangible Book Value per Share	12.91	12.6	12.76	12.13	12.02	13.99	14.12	13.53	14.05	13.92	14.46	19.09	17.07	14.84	13.07

Healthcare Realty Trust Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)